Wave Life Sciences, Inc.
WVE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001631574
In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.
13F holders, Q2 2025
Institutional positions in Wave Life Sciences, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 177
- −17 vs. Q1 2025
- Shares held
- 138.9M
- +7.62M (+5.8%) vs. Q1 2025
- Total value
- $903.1M
- −$158.3M (−14.9%) vs. Q1 2025
- New holders
- 23
- 84 more added
- Sold out
- 40
- 39 more reduced
3 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting WVE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 239 | $1.06B |
| Q1 2026 | 232 | $1.25B |
| Q4 2025 | 219 | $3.11B |
| Q3 2025 | 189 | $1.05B |
| Q2 2025 | 177 | $903.1M |
| Q1 2025 | 197 | $1.06B |
| Q4 2024 | 184 | $1.59B |
| Q3 2024 | 162 | $986.1M |
| Q2 2024 | 144 | $474.4M |
| Q1 2024 | 132 | $572.3M |
| Q4 2023 | 115 | $468.0M |
| Q3 2023 | 85 | $417.4M |
| Q2 2023 | 81 | $262.7M |
| Q1 2023 | 73 | $303.5M |
| Q4 2022 | 75 | $476.9M |
| Q3 2022 | 61 | $242.8M |
| Q2 2022 | 60 | $220.3M |
| Q1 2022 | 82 | $95.4M |
| Q4 2021 | 90 | $148.5M |
| Q3 2021 | 88 | $183.5M |
| Q2 2021 | 87 | $246.7M |
| Q1 2021 | 102 | $214.8M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Wave Life Sciences, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Allostery Investments LP | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −16,093−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −12,643−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −12,151−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −11,158−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −10,830−100.0% | Sold out |
| Ascent Group, LLC | 0 | $0 | 0.00% | −10,237−100.0% | Sold out |
| KBC Group NV | 0 | $0 | 0.00% | −5,440−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −4,397−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −2,396−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −369−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −348−100.0% | Sold out |
| TD Private Client Wealth LLC | 0 | $0 | 0.00% | −126−100.0% | Sold out |
| Creative Financial Designs Inc | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −54−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Glenmede Trust Co NA | – | – | – | – | Not filed |
| Orion Portfolio Solutions, LLC | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |